Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 11, 2025, titled ""Glenmark Pharmaceuticals Inc., USA to launch Leucovorin Calcium for Injection USP, 350 mg/vial Single-Dose Vial"".